Medchemica Consultancy LIMITED
Newcastle-under-Lyme, England
- UEI
- EU2YREXCD4N6
- CAGE
- U1UE0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- Newcastle-under-Lyme, Newcastle ST5 2BE, UK
- Website
- medchemica.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 89 Services, Not Elsewhere Classified
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Sloan-Kettering Institute For Cancer Research | U19AI171399 | $38,745 |
Similar vendors
About the company
Medchemica Consultancy LIMITED, operating through its Medchemica Consultancy LTD Division, is a foreign-owned, for-profit organization registered as a corporate entity with tax-exempt status in the U.S. federal government's System for Award Management (SAM). The company specializes in providing consultancy services related to medicinal chemistry and drug discovery, particularly in the areas of fragment-to-lead target validation and lead optimization. Medchemica Consultancy LIMITED has been registered in SAM.gov since September 2, 2021, with its current registration set to expire on August 30, 2024. The company's expertise appears to be focused on early-stage drug development processes, offering specialized knowledge in the field of pharmaceutical research and development.
The company has received multiple federal grant sub-awards, primarily in collaboration with the Sloan-Kettering Institute for Cancer Research. These sub-awards have been focused on two main areas of research: fragment-to-lead target validation and lead optimization. One notable sub-award (ID: U19AI171399MSKSUB00000100EU2YREXCD4N6) was specifically for "FRAGMENT-TO-LEAD TARGET VALIDATION," indicating the company's involvement in early-stage drug discovery processes. Two other sub-awards (IDs: 148733020MSKSUB00000103EU2YREXCD4N6 and U19AI171399MSKSUB00000103EU2YREXCD4N6) were both described as "PROJECT 5: LEAD OPTIMIZATION," suggesting ongoing work in refining potential drug candidates. These projects appear to be part of larger research initiatives, likely in the field of cancer research or drug development, given the involvement of the Sloan-Kettering Institute for Cancer Research as the prime grantee.
Quick answers
Is Medchemica Consultancy LIMITED registered in SAM.gov?
Yes. Medchemica Consultancy LIMITED's SAM.gov registration is active through July 10, 2027.
On GovTribe
See Medchemica Consultancy LIMITED's full federal record
- Similar vendors